TSE:CRON Cronos Group (CRON) Stock Price, News & Analysis C$2.43 -0.02 (-0.82%) As of 04/17/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesBuy This Stock About Cronos Group Stock (TSE:CRON) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cronos Group alerts:Sign Up Key Stats Today's RangeC$2.37▼C$2.4950-Day RangeC$2.29▼C$2.9552-Week RangeC$2.27▼C$4.28Volume82,213 shsAverage Volume257,433 shsMarket CapitalizationC$641.68 millionP/E RatioN/ADividend YieldN/APrice TargetC$3.54Consensus RatingN/A Company OverviewCronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.Read More… Cronos Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks31st Percentile Overall ScoreCRON MarketRank™: Cronos Group scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingN/A Amount of Analyst CoverageCronos Group has received no research coverage in the past 90 days.Read more about Cronos Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is -13.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is -13.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioCronos Group has a PEG Ratio of 0.12. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 0.82. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for CRON. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for CRON. News and Social Media2.3 / 5News Sentiment0.16 News SentimentCronos Group has a news sentiment score of 0.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Cronos Group this week, compared to 0 articles on an average week.Search Interest1 people have searched for CRON on MarketBeat in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by Insiders46.40% of the stock of Cronos Group is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 15.99% of the stock of Cronos Group is held by institutions.Read more about Cronos Group's insider trading history. Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CRON Stock News HeadlinesHow Cronos: The New Dawn Can Outdo The Callisto ProtocolApril 17 at 3:20 AM | msn.comNew Fiat Cronos Lands at Dealerships Before Its RevealApril 13, 2025 | msn.comNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. April 20, 2025 | Porter & Company (Ad)Cronos Group price target lowered to $1.65 from $2 at BofAApril 8, 2025 | markets.businessinsider.comCronos Group Inc.: Cronos Appoints Anna Shlimak as Chief Financial OfficerMarch 19, 2025 | finanznachrichten.deCronos Group's (TSE:CRON) Solid Earnings Are Supported By Other Strong FactorsMarch 6, 2025 | finance.yahoo.comTSX Penny Stocks Spotlight: Cronos Group And 2 Other Noteworthy PicksMarch 4, 2025 | uk.finance.yahoo.comCronos Group Inc.: Cronos Group Reports 2024 Fourth Quarter and Full-Year ResultsMarch 1, 2025 | finanznachrichten.deSee More Headlines CRON Stock Analysis - Frequently Asked Questions How have CRON shares performed this year? Cronos Group's stock was trading at C$2.89 at the beginning of 2025. Since then, CRON shares have decreased by 15.9% and is now trading at C$2.43. View the best growth stocks for 2025 here. How do I buy shares of Cronos Group? Shares of CRON stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), NIO (NIO) and Aurora Cannabis (ACB). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryPharmaceutical Products Current SymbolTSE:CRON CIKN/A Webwww.thecronosgroup.com Phone416-504-0004FaxN/AEmployees450Year FoundedN/APrice Target and Rating Average Stock Price TargetC$3.54 High Stock Price TargetC$3.54 Low Stock Price TargetC$3.54 Potential Upside/Downside+45.7%Consensus RatingN/A Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.18) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth0.12Net IncomeC$-32,779,583.58 Net Margins-42.65% Pretax MarginN/A Return on Equity-4.40% Return on Assets-3.73% Debt Debt-to-Equity Ratio0.17 Current Ratio24.24 Quick Ratio24.01 Sales & Book Value Annual SalesC$76.86 million Price / Sales8.35 Cash FlowC$1.45 per share Price / Cash Flow1.67 Book ValueC$2.96 per share Price / Book0.82Miscellaneous Outstanding Shares264,064,704Free FloatN/AMarket CapC$641.68 million OptionableNot Optionable Beta1.02 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (TSE:CRON) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Top Secret $9 Trillion AI SuperweaponJeff Brown spotted Nvidia at $1. Now he’s revealing a new AI superweapon — and the Musk-connected stocks that ...Brownstone Research | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.